These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 38132315)

  • 1. New Frontiers in
    Shareef O; Shareef S; Saeed HN
    Biology (Basel); 2023 Dec; 12(12):. PubMed ID: 38132315
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of Confocal Microscopy for the Diagnosis of Polymerase Chain Reaction-Positive Acanthamoeba Keratitis: A Case-Control Study.
    De Craene S; Knoeri J; Georgeon C; Kestelyn P; Borderie VM
    Ophthalmology; 2018 Feb; 125(2):161-168. PubMed ID: 28965660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acanthamoeba Keratitis: A Single-Institution Series of Four Cases With Literature Review.
    Smith C; Ashraf N; Haghnegahdar M; Goins K; Newman JR
    Cureus; 2022 Jan; 14(1):e21112. PubMed ID: 35165570
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in the management of Acanthamoeba keratitis: A review of the literature and synthesized algorithmic approach.
    Kaufman AR; Tu EY
    Ocul Surf; 2022 Jul; 25():26-36. PubMed ID: 35462076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rising tide of Acanthamoeba keratitis in Auckland, New Zealand: a 7-year review of presentation, diagnosis and outcomes (2009-2016).
    McKelvie J; Alshiakhi M; Ziaei M; Patel DV; McGhee CN
    Clin Exp Ophthalmol; 2018 Aug; 46(6):600-607. PubMed ID: 29412494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acanthamoeba keratitis].
    Bouheraoua N; Labbé A; Chaumeil C; Liang Q; Laroche L; Borderie V
    J Fr Ophtalmol; 2014 Oct; 37(8):640-52. PubMed ID: 25169145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of implementation of polymerase chain reaction on diagnosis, treatment, and clinical course of Acanthamoeba keratitis.
    Roth M; Balasiu A; Daas L; Holtmann C; Servera A; Walckling M; MacKenzie CR; Fuchsluger TA; Geerling G
    Graefes Arch Clin Exp Ophthalmol; 2023 Jul; 261(7):1951-1959. PubMed ID: 36795161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of
    Avdagic E; Chew HF; Veldman P; Tu EY; Jafri M; Doshi R; Boggild AK; Reidy JJ; Farooq AV
    Ocul Immunol Inflamm; 2021 Feb; 29(2):278-281. PubMed ID: 31829774
    [No Abstract]   [Full Text] [Related]  

  • 9. Current advances in diagnostic methods of Acanthamoeba keratitis.
    Wang Y; Feng X; Jiang L
    Chin Med J (Engl); 2014; 127(17):3165-70. PubMed ID: 25189964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing and monitoring the characteristics of Acanthamoeba keratitis using slit scanning and laser scanning in vivo confocal microscopy.
    Curro-Tafili K; Verbraak FD; de Vries R; van Nispen RMA; Ghyczy EAE
    Ophthalmic Physiol Opt; 2024 Jan; 44(1):131-152. PubMed ID: 37916883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of miltefosine in the management of refractory Acanthamoeba keratitis.
    Tavassoli S; Buckle M; Tole D; Chiodini P; Darcy K
    Cont Lens Anterior Eye; 2018 Aug; 41(4):400-402. PubMed ID: 29580956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of In Vivo Confocal Microscopy, PCR and Culture of Corneal Scrapes in the Diagnosis of Acanthamoeba Keratitis.
    Goh JWY; Harrison R; Hau S; Alexander CL; Tole DM; Avadhanam VS
    Cornea; 2018 Apr; 37(4):480-485. PubMed ID: 29256983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Review on Acanthamoeba Keratitis: An Overview of Epidemiology, Risk Factors, and Therapeutic Strategies.
    Garg D; Daigavane S
    Cureus; 2024 Aug; 16(8):e67803. PubMed ID: 39328676
    [No Abstract]   [Full Text] [Related]  

  • 14. Presumed late recurrence of Acanthamoeba keratitis exacerbated by exposure to topical corticosteroids.
    Patel DV; McGhee CNj
    Oman J Ophthalmol; 2013 Sep; 6(Suppl 1):S40-2. PubMed ID: 24391372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral miltefosine for refractory
    Hirabayashi KE; Lin CC; Ta CN
    Am J Ophthalmol Case Rep; 2019 Dec; 16():100555. PubMed ID: 31650083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A descriptive case of persistent
    Connelly L; Anijeet D; Alexander CL
    Access Microbiol; 2020; 2(3):acmi000084. PubMed ID: 32974565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Diagnostic Potential of Chorismate Mutase Poly-Clonal Peptide Antibody for the
    Kim MJ; Jo HJ; Sohn HJ; Shin HJ; Quan FS; Kong HH; Moon EK
    Pathogens; 2023 Mar; 12(4):. PubMed ID: 37111412
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.
    Robaei D; Carnt N; Minassian DC; Dart JK
    Ophthalmology; 2014 Jul; 121(7):1383-8. PubMed ID: 24630688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymicrobial keratitis: Acanthamoeba and infectious crystalline keratopathy.
    Tu EY; Joslin CE; Nijm LM; Feder RS; Jain S; Shoff ME
    Am J Ophthalmol; 2009 Jul; 148(1):13-9.e2. PubMed ID: 19327742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Miltefosine as Adjunctive Treatment for Recalcitrant Acanthamoeba Keratitis.
    Dewan N; Ming W; Holland SP; Yeung SN; Iovieno A
    Cornea; 2019 Jul; 38(7):914-917. PubMed ID: 31170106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.